Redmile Group, LLC Insmed Inc Transaction History

Redmile Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$18.95 - $28.08 $38.5 Million - $57.1 Million	-2,033,492 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$20.0 - $29.72 $2.66 Million - $3.95 Million	-132,870 Reduced 6.13%	2,033,492 $48.1 Million
Q1 2018 May 15, 2018	SELL	$21.69 - $32.99 $1.8 Million - $2.73 Million	-82,900 Reduced 3.69%	2,166,362 $0
Q4 2017 Feb 14, 2018	BUY	$26.43 - $31.78 $6.81 Million - $8.19 Million	257,616 Added 12.93%	2,249,262 $70.1 Million
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $23.1 Million - $62.2 Million	1,991,646	1,991,646 $62.2 Million

484

182M

2.14M

3.25M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10.6B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.